CIK 0001665988 · Accelerated filer<br>Emerging growth company
Bioventus Inc.
Sign in to watch- Ticker
- BVS
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 810980861
- Phone
- (919) 474-6700
- Business address
- 4721 EMPEROR BOULEVARD, SUITE 100, DURHAM, NC, 27703
- 8-K Event Results of operations
- ARS Other Annual Report to Security Holders
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 4/A Derivatives Options or other derivatives
- 4/A Derivatives Options or other derivatives
- 4 Shares withheld for taxes SVP & CFO gave up 5,648 shares (to pay taxes)
- 4 Shares withheld for taxes SVP & Chief Compliance Officer gave up 1,868 shares (to pay taxes)
- 4 Shares withheld for taxes SVP & General Counsel gave up 4,312 shares (to pay taxes)
- 4 Shares withheld for taxes SVP & CFO gave up 8,091 shares (to pay taxes)
- 4 Shares withheld for taxes SVP & CFO gave up 5,865 shares (to pay taxes)
- 4 Shares withheld for taxes SVP & Chief Compliance Officer gave up 3,022 shares (to pay taxes)
- 4 Shares withheld for taxes SVP & General Counsel gave up 7,663 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 14,553 shares (to pay taxes)
- 4 Open-market sale Director sold 12,000 shares at $8.79 ($105,439)
- 144 Insider Sale of Securities
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-K Report Annual Report
- 8-K Event Results of operations
- 4 Shares withheld for taxes SVP & CFO gave up 9,429 shares (to pay taxes)
Page 2 of 24 · 463 filings